JPMorgan Chase & Co’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91K | Sell |
5,207
-60,545
| -92% | -$22.2K | ﹤0.01% | 5660 |
|
|
2025
Q1 | $17K | Sell |
65,752
-114,623
| -64% | -$29.7K | ﹤0.01% | 5335 |
|
|
2024
Q4 | $101K | Buy |
180,375
+119,041
| +194% | +$67K | ﹤0.01% | 4772 |
|
|
2024
Q3 | $36.8K | Buy |
61,334
+39,101
| +176% | +$23.5K | ﹤0.01% | 5065 |
|
|
2024
Q2 | $60K | Sell |
22,233
-114,976
| -84% | -$310K | ﹤0.01% | 4834 |
|
|
2024
Q1 | $704K | Buy |
137,209
+136,968
| +56,833% | +$703K | ﹤0.01% | 3760 |
|
|
2023
Q4 | $129 | Sell |
241
-9,734
| -98% | -$5.21K | ﹤0.01% | 6056 |
|
|
2023
Q3 | $6.61K | Sell |
9,975
-5,162
| -34% | -$3.42K | ﹤0.01% | 5388 |
|
|
2023
Q2 | $23K | Sell |
15,137
-7,210
| -32% | -$11K | ﹤0.01% | 5022 |
|
|
2023
Q1 | $42K | Buy |
22,347
+18,107
| +427% | +$34K | ﹤0.01% | 4954 |
|
|
2022
Q4 | $4K | Buy |
+4,240
| New | +$4K | ﹤0.01% | 5252 |
|